Literature DB >> 16187692

Calcium sensitization as a pharmacological target in vascular smooth-muscle regulation.

George Christ1, Christopher Wingard.   

Abstract

Numerous diseases have been associated with alteration(s) in smooth-muscle cell tone (ie, heightened contraction and/or diminished relaxation), including vascular disorders such as hypertension, cerebral vasospasm, coronary vasospasm and erectile dysfunction. Given the numerous steps that occur between receptor activation, signal transduction and cellular activation in vascular smooth muscle, it is not surprising that the etiology of common cardiovascular diseases/disorders is multifactorial. Nonetheless, this review will highlight the potential importance of the relationship between intracellular calcium levels and force generation, referred to as calcium sensitization, to these disease processes. As such, the complexities of the overlapping biochemical systems/pathways that govern calcium sensitization in vascular myocytes are reviewed, and the possibility that alterations in calcium sensitization may provide a common link among distinct vascular disorders is explored. A corollary of this supposition is that improved knowledge and understanding of the intrinsically complex regulation of calcium sensitization will provide novel opportunities for improved therapy of vascular disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187692

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  7 in total

1.  Urotensin II alters vascular reactivity in animals subjected to volume overload.

Authors:  Gregory S Harris; Robert M Lust; Laxmansa C Katwa; Christopher J Wingard
Journal:  Peptides       Date:  2010-08-17       Impact factor: 3.750

2.  Emodin inhibits tonic tension through suppressing PKCδ-mediated inhibition of myosin phosphatase in rat isolated thoracic aorta.

Authors:  Kyung-Min Lim; Jae-Hyuk Kwon; Keunyoung Kim; Ji-Yoon Noh; Seojin Kang; Jung-Min Park; Moo-Yeol Lee; Ok-Nam Bae; Jin-Ho Chung
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

3.  PVP formulated fullerene (C60) increases Rho-kinase dependent vascular tissue contractility in pregnant Sprague Dawley rats.

Authors:  Achini K Vidanapathirana; Leslie C Thompson; Erin E Mann; Jillian T Odom; Nathan A Holland; Susan J Sumner; Li Han; Anita H Lewin; Timothy R Fennell; Jared M Brown; Christopher J Wingard
Journal:  Reprod Toxicol       Date:  2014-08-01       Impact factor: 3.143

4.  Vascular Tissue Contractility Changes Following Late Gestational Exposure to Multi-Walled Carbon Nanotubes or their Dispersing Vehicle in Sprague Dawley Rats.

Authors:  A K Vidanapathirana; L C Thompson; J Odom; N A Holland; S J Sumner; T R Fennell; J M Brown; C J Wingard
Journal:  J Nanomed Nanotechnol       Date:  2014-04-20

5.  Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.

Authors:  Christopher J Wingard; Fatiha Moukdar; Raju Y Prasad; Brook L Cathey; Lois Wilkinson
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

6.  Cardiovascular effects of a novel potent and highly selective azaindole-based inhibitor of Rho-kinase.

Authors:  R Kast; H Schirok; S Figueroa-Pérez; J Mittendorf; M J Gnoth; H Apeler; J Lenz; J K Franz; A Knorr; J Hütter; M Lobell; K Zimmermann; K Münter; K H Augstein; H Ehmke; J P Stasch
Journal:  Br J Pharmacol       Date:  2007-10-15       Impact factor: 8.739

7.  α-Isocubebene modulates vascular tone by inhibiting myosin light chain phosphorylation in murine thoracic aorta.

Authors:  Byeong Hyeok Ye; Eun Jung Kim; Seung Eun Baek; Young Whan Choi; So Youn Park; Chi Dae Kim
Journal:  Korean J Physiol Pharmacol       Date:  2018-06-25       Impact factor: 2.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.